BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 9873717)

  • 1. Effects on polo-like kinase 1 polo-box domain binding affinities of peptides incurred by structural variation at the phosphoamino acid position.
    Qian W; Park JE; Liu F; Lee KS; Burke TR
    Bioorg Med Chem; 2013 Jul; 21(14):3996-4003. PubMed ID: 22743087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arylstibonic acids are potent and isoform-selective inhibitors of Cdc25a and Cdc25b phosphatases.
    Mak LH; Knott J; Scott KA; Scott C; Whyte GF; Ye Y; Mann DJ; Ces O; Stivers J; Woscholski R
    Bioorg Med Chem; 2012 Jul; 20(14):4371-6. PubMed ID: 22705189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of nonpeptidic, small molecule inhibitors for the Mycobacterium tuberculosis protein tyrosine phosphatase PtpB.
    Rawls KA; Grundner C; Ellman JA
    Org Biomol Chem; 2010 Sep; 8(18):4066-70. PubMed ID: 20644889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A two stage click-based library of protein tyrosine phosphatase inhibitors.
    Xie J; Seto CT
    Bioorg Med Chem; 2007 Jan; 15(1):458-73. PubMed ID: 17046267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based prediction of free energy changes of binding of PTP1B inhibitors.
    Wang J; Chan SL; Ramnarayan K
    J Comput Aided Mol Des; 2003 Aug; 17(8):495-513. PubMed ID: 14703121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of inhibitor-sensitive protein tyrosine phosphatases via active-site mutations.
    Bishop AC; Zhang XY; Lone AM
    Methods; 2007 Jul; 42(3):278-88. PubMed ID: 17532515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for inhibition of the protein tyrosine phosphatase 1B by phosphotyrosine peptide mimetics.
    Groves MR; Yao ZJ; Roller PP; Burke TR; Barford D
    Biochemistry; 1998 Dec; 37(51):17773-83. PubMed ID: 9922143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular modeling of protein tyrosine phosphatase 1B (PTP 1B) inhibitors.
    Murthy VS; Kulkarni VM
    Bioorg Med Chem; 2002 Apr; 10(4):897-906. PubMed ID: 11836096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based design and discovery of novel inhibitors of protein tyrosine phosphatases.
    Huang P; Ramphal J; Wei J; Liang C; Jallal B; McMahon G; Tang C
    Bioorg Med Chem; 2003 Apr; 11(8):1835-49. PubMed ID: 12659770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent non-peptidyl inhibitors of protein tyrosine phosphatase 1B.
    Taylor SD; Kotoris CC; Dinaut AN; Wang Q; Ramachandran C; Huang Z
    Bioorg Med Chem; 1998 Sep; 6(9):1457-68. PubMed ID: 9801817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTP-1B inhibitors: cyclopenta[d][1,2]-oxazine derivatives.
    Cho SY; Baek JY; Han SS; Kang SK; Ha JD; Ahn JH; Lee JD; Kim KR; Cheon HG; Rhee SD; Yang SD; Yon GH; Pak CS; Choi JK
    Bioorg Med Chem Lett; 2006 Feb; 16(3):499-502. PubMed ID: 16289879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel phosphate mimetics for the design of non-peptidyl inhibitors of protein tyrosine phosphatases.
    Kotoris CC; Chen MJ; Taylor SD
    Bioorg Med Chem Lett; 1998 Nov; 8(22):3275-80. PubMed ID: 9873717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bidentate inhibitors of protein tyrosine phosphatases.
    Low JL; Chai CL; Yao SQ
    Antioxid Redox Signal; 2014 May; 20(14):2225-50. PubMed ID: 24206395
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.